Recent research has shown how weight-loss and diabetes medications, also known as glucagon-like peptide-1 receptor agonists (GLP-1s), can help with a variety of other conditions. This includes ...

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported by the biotechnology company uniQure this week. Huntington’s is an ...

The US government’s shutdown is shaking the nation at a time when public health staffing has already been reduced, the threat of disease outbreaks looms, and both the respiratory virus season and ...

Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

The parasitic kissing bug disease is not new, but it has become increasingly common to the point of being endemic in the U.S. Because of this, the insect-borne illness has been a point of interest for ...

Earlier this year, two new DMAs were established following detections of CWD in both wild and captive deer: Disease Management Area 9 (DMA 9): Portions of Carbon, Columbia, Luzerne and Schuylkill ...

Kentucky's most common deer is experiencing a disease outbreak, prompting a warning from the state.The Kentucky Department of Fish and Wildlife Resources posted Thursday that there is an outbreak of ...

Oct 1 (Reuters) - Fortress Biotech (FBIO.O), opens new tab on Wednesday said the U.S. Food and Drug Administration declined to approve the drug it is developing with Indian drugmaker Zydus ...

An experimental gene therapy has become the first treatment to successfully slow the progression of Huntington’s disease. While the findings are still preliminary, the approach could be a major ...

– Late-breaking presentation at ESC Congress 2025 confirms that early, persistent lowering of LDL-C and blood pressure leads to improved cardiovascular health outcomes – – Raised over $50 million to ...